On September 4, 2026, Lazard Asset Management LLC bought 959,600 shares of SINOPHARM (H shares) at an average of HKD 15.6782 per share, involving about HKD 15.04 million.
Prior to the acquisition, Lazard Asset Management LLC's long position in SINOPHARM was 186.96 million shares, representing 13.93%; following the acquisition, the holding changed to 187.92 million shares, with the long position ratio rising to 14.0%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.